Literature DB >> 34173837

DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity.

Jannigje Rachel Kok1, Nelma M Palminha2,3, Cleide Dos Santos Souza1, Sherif F El-Khamisy4,5,6, Laura Ferraiuolo7,8.   

Abstract

Increasing evidence supports the involvement of DNA damage in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Elevated levels of DNA damage are consistently observed in both sporadic and familial forms of ALS and may also play a role in Western Pacific ALS, which is thought to have an environmental cause. The cause of DNA damage in ALS remains unclear but likely differs between genetic subgroups. Repeat expansion in the C9ORF72 gene is the most common genetic cause of familial ALS and responsible for about 10% of sporadic cases. These genetic mutations are known to cause R-loops, thus increasing genomic instability and DNA damage, and generate dipeptide repeat proteins, which have been shown to lead to DNA damage and impairment of the DNA damage response. Similarly, several genes associated with ALS including TARDBP, FUS, NEK1, SQSTM1 and SETX are known to play a role in DNA repair and the DNA damage response, and thus may contribute to neuronal death via these pathways. Another consistent feature present in both sporadic and familial ALS is the ability of astrocytes to induce motor neuron death, although the factors causing this toxicity remain largely unknown. In this review, we summarise the evidence for DNA damage playing a causative or secondary role in the pathogenesis of ALS as well as discuss the possible mechanisms involved in different genetic subtypes with particular focus on the role of astrocytes initiating or perpetuating DNA damage in neurons.
© 2021. The Author(s).

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Astrocytes; DNA damage; DNA damage response; Neurodegeneration

Mesh:

Year:  2021        PMID: 34173837      PMCID: PMC8316199          DOI: 10.1007/s00018-021-03872-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  214 in total

1.  Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Authors:  Sarah J Hill; Daniel A Mordes; Lisa A Cameron; Donna S Neuberg; Serena Landini; Kevin Eggan; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 2.  Astrocytes: form, functions, and roles in disease.

Authors:  D L Montgomery
Journal:  Vet Pathol       Date:  1994-03       Impact factor: 2.221

3.  The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks.

Authors:  Klara Acs; Martijn S Luijsterburg; Leena Ackermann; Florian A Salomons; Thorsten Hoppe; Nico P Dantuma
Journal:  Nat Struct Mol Biol       Date:  2011-11-27       Impact factor: 15.369

4.  Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage.

Authors:  Xu-Dong Wang; Min-Wei Zhu; Dan Shan; Shu-Yu Wang; Xiang Yin; Yue-Qing Yang; Tian-Hang Wang; Chun-Ting Zhang; Ying Wang; Wei-Wei Liang; Jun Zhang; Hai-Zhi Jiang; Guang-Tao Dong; Hong-Quan Jiang; Yan Qi; Hong-Lin Feng
Journal:  DNA Repair (Amst)       Date:  2018-12-21

5.  Autophagy Regulates Chromatin Ubiquitination in DNA Damage Response through Elimination of SQSTM1/p62.

Authors:  Yanan Wang; Nan Zhang; Luyao Zhang; Ran Li; Wan Fu; Ke Ma; Xue Li; Lina Wang; Jiadong Wang; Hongquan Zhang; Wei Gu; Wei-Guo Zhu; Ying Zhao
Journal:  Mol Cell       Date:  2016-06-23       Impact factor: 17.970

6.  Excitotoxic potential of the cyanotoxin β-methyl-amino-L-alanine (BMAA) in primary human neurons.

Authors:  Alexander S Chiu; Michelle M Gehringer; Nady Braidy; Gilles J Guillemin; Jeffrey H Welch; Brett A Neilan
Journal:  Toxicon       Date:  2012-08-09       Impact factor: 3.033

7.  Exosome secretion is a key pathway for clearance of pathological TDP-43.

Authors:  Yohei Iguchi; Lara Eid; Martin Parent; Geneviève Soucy; Christine Bareil; Yuichi Riku; Kaori Kawai; Shinnosuke Takagi; Mari Yoshida; Masahisa Katsuno; Gen Sobue; Jean-Pierre Julien
Journal:  Brain       Date:  2016-09-27       Impact factor: 13.501

8.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

9.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

10.  CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.

Authors:  Emmanuelle C Genin; Morgane Plutino; Sylvie Bannwarth; Elodie Villa; Eugenia Cisneros-Barroso; Madhuparna Roy; Bernardo Ortega-Vila; Konstantina Fragaki; Françoise Lespinasse; Estefania Pinero-Martos; Gaëlle Augé; David Moore; Florence Burté; Sandra Lacas-Gervais; Yusuke Kageyama; Kie Itoh; Patrick Yu-Wai-Man; Hiromi Sesaki; Jean-Ehrland Ricci; Cristofol Vives-Bauza; Véronique Paquis-Flucklinger
Journal:  EMBO Mol Med       Date:  2016-01-01       Impact factor: 12.137

View more
  13 in total

Review 1.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

Review 2.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

3.  Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases.

Authors:  Nan Qin; Anke Geng; Renhao Xue
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

4.  Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina.

Authors:  Emily E Brown; Michael J Scandura; Sudeep Mehrotra; Yekai Wang; Jianhai Du; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

Review 5.  DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis.

Authors:  Anna Konopka; Julie D Atkin
Journal:  Front Aging Neurosci       Date:  2022-04-27       Impact factor: 5.702

Review 6.  Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.

Authors:  Bridget C Benson; Pamela J Shaw; Mimoun Azzouz; J Robin Highley; Guillaume M Hautbergue
Journal:  Front Neurosci       Date:  2021-12-23       Impact factor: 4.677

7.  Defective repair of topoisomerase I induced chromosomal damage in Huntington's disease.

Authors:  Nelma M Palminha; Cleide Dos Santos Souza; Jon Griffin; Chunyan Liao; Laura Ferraiuolo; Sherif F El-Khamisy
Journal:  Cell Mol Life Sci       Date:  2022-02-28       Impact factor: 9.207

Review 8.  The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases.

Authors:  Sina Shadfar; Mariana Brocardo; Julie D Atkin
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

9.  A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.

Authors:  Gaël Nicolas; Myriam Sévigny; François Lecoquierre; Florent Marguet; Andréanne Deschênes; Maria Carment Del Pelaez; Sébastien Feuillette; Anaïs Audebrand; Magalie Lecourtois; Stéphane Rousseau; Anne-Claire Richard; Kévin Cassinari; Vincent Deramecourt; Charles Duyckaerts; Anne Boland; Jean-François Deleuze; Vincent Meyer; Jordi Clarimon Echavarria; Ellen Gelpi; Haruhiko Akiyama; Masato Hasegawa; Ito Kawakami; Tsz H Wong; Jeroen G J Van Rooij; John C Van Swieten; Dominique Campion; Paul A Dutchak; David Wallon; Flavie Lavoie-Cardinal; Annie Laquerrière; Anne Rovelet-Lecrux; Chantelle F Sephton
Journal:  Acta Neuropathol Commun       Date:  2022-02-12       Impact factor: 7.801

Review 10.  The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.

Authors:  Stephanie M Boas; Kathlene L Joyce; Rita M Cowell
Journal:  Antioxidants (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.